Patents by Inventor Maravillas Bordell

Maravillas Bordell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POLYMORPH OF 4-[2-[4-[1-(2-ETHOXYETHYL)-1H-BENZIMIDAZOLE-2-YL]-1-PIPERIDINYL]ETHYL]-alpha alpha-DIMETHYL-BENZENEACETIC ACID
    Publication number: 20100004285
    Abstract: Crystalline form 1 4-[2-[4-[1 -(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]-ethyl]-??-dimethyl-benzeneacetic acid of formula (I) is described, procedures for its preparation, pharmaceutical formulae containing crystalline form 1 and the use of crystalline form 1 to treat allergic reactions and pathological processes mediated by histamine in mammals such as man.
    Type: Application
    Filed: September 16, 2009
    Publication date: January 7, 2010
    Applicant: FAES FARMA, S.A.
    Inventors: Aurelio Orjales Venero, Maravillas Bordell Martin, Gonzalo Canal Mori, Haydee Blanco Fuente, Maria Luisa Lucero De Pablo, Victor Rubio Royo, Ramon Mosquera Pestaña
  • 4-[(3-FLUOROPHENOXY)PHENYLMETHYL]PIPERIDINE METHANESULFONATE: USES, PROCESS OF SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100004283
    Abstract: The present patent application is directed to 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonic acid salt (formula I), its synthesis and use in the manufacture of a medicament for the treatment and/or prevention of a serotonine and/or norepinephrine mediated disease or condition. The present invention is also directed to pharmaceutical compositions comprising the same.
    Type: Application
    Filed: April 12, 2007
    Publication date: January 7, 2010
    Applicant: FAES FARMA, S.A.
    Inventors: Aurelio Orjales Venero, Ramon Mosquera Pestana, Maria Carmen Pumar Duran, Antonio Toledo Avello, Gonzalo Canal Mori, Maravillas Bordell Martin
  • Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-??-dimethyl-benzeneacetic acid
    Patent number: 7612095
    Abstract: Crystalline form 1 of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1 -piperidinyl]ethyl]-??-dimethyl-benzen?eacetic acid Crystalline form 1 of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1 -piperidinyl]ethyl]-??-dimethyl-benzen?eacetic acid of formula (I) is described, procedures for its preparation, pharmaceutical formulae containing crystalline form 1 and the use of crystalline form 1 to treat allergic reactions and pathological processes mediated by histamine in mammals such as man.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: November 3, 2009
    Assignee: Faes Farma, S.A.
    Inventors: Aurelio Orjales Venero, Maravillas Bordell Martin, Gonzalo Canal Mori, Haydee Blanco Fuente, Maria Luisa Lucero De Pablo, Victor Rubio Royo, Ramon Mosquera Pestaña
  • 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
    Publication number: 20070265306
    Abstract: The present patent application is directed to 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonic acid salt (formula I), its synthesis and a method for treating and/or preventing a serotonine and/or norepinephrine mediated disease or condition. The present invention is also directed to pharmaceutical compositions comprising the same.
    Type: Application
    Filed: July 13, 2006
    Publication date: November 15, 2007
    Inventors: Aurelio Orjales Venero, Ramon Mosquera Pestana, Maria Carmen Pumar Duran, Antonio Toledo Avello, Gonzalo Canal Mori, Maravillas Bordell Martin
  • Polymorph of acid4-[2-[4-[1-(2-ethoxyethyl)-1h-benzimidazole-2-1l]-1piperidinyl]ethyl]-$g(a), $g(a)-dimetiiyl-benzeneacetic
    Publication number: 20050203141
    Abstract: Polymorph 1 of 4-[2-[1-(2-ethoxyethyl)-1H-benzidimazole-2-yl]-1-piperidinyl]ethyl]-??-dimethyl-benzenoacetic acid of formula (I) is described, procedures for its preparation, pharmaceutical formulae containing polymorph 1 and the use of polymorph 1 to treat allergic reactions and pathological processes mediated by histamine in mammals such as man.
    Type: Application
    Filed: April 19, 2002
    Publication date: September 15, 2005
    Inventors: Aurelio Orjales Venero, Maravillas Bordell Martin, Gonzalo Canal Mori, Haydee Blanco Fuente, Maria Luisa Lucero De Pablo, Victor Rubio Royo, Ramon Mosquera Pestana
  • Benzimidazole derivatives with antihistaminic activity
    Patent number: 5877187
    Abstract: New benzimidazole derivatives of formula: ##STR1## in which R.sub.1 is H or a short chain hydrocarbon group such as methyl, hyl, isopropyl, cyclopropyl, vinyl, etc., and R.sub.2 is a group selected from among the following: CH.sub.2 OH, COOH, COOR.sub.3 and 4,4-dimethyl-2-oxazolinyl, R.sub.3 being a short chain alkyl group such as methyl, ethyl, etc., are described.A description is also made of the preparation of these compounds, which have a high H.sub.1 antihistaminic and antiallergic activity and are devoid of effects on the central nervous and cardiovascular systems.
    Type: Grant
    Filed: June 4, 1997
    Date of Patent: March 2, 1999
    Assignee: Fabrica Espanola de Productos Quimicos y Farmaceuticos S.A. (FAES)
    Inventors: Aurelio Orjales, Victor Rubio, Maravillas Bordell